| |
Portugal
|
UK
|
Total
|
|---|
|
Crude
|
16.5 [13.1;20.5]
|
20.0 [16.6;24.0]
|
18.4 [15.9;21.2]
|
|
IPW complete cases
|
17.5 [14.4;21.1]
|
20.5 [17.9;23.3]
|
19.4 [17.4;21.6]
|
|
% Change in prevalencea
|
6.1%
|
2.5%
|
5.4%
|
|
IPW imputed cases
|
18.3 [14.1;22.6]
|
20.8 [16.7;25.0]
|
20.0 [16.9;23.1]
|
|
% Change in prevalence
|
10.9%
|
4.0%
|
8.7%
|
|
MI (total population)
|
17.4 [13.4;21.4]
|
21.9 [17.9;26.0]
|
20.4 [17.3;23.4]
|
|
% Change in prevalence
|
5.5%
|
9.5%
|
10.9%
|
|
MI (Responders)
|
17.1 [13.3;20.8]
|
19.7 [16.1;23.4]
|
18.6 [16.0;21.2]
|
|
% Change in prevalence
|
3.6%
|
−1.5%
|
1.1%
|
|
MI (Non-responders)
|
18.1 [8.9;27.2]
|
23.9 [17.2;30.6]
|
23.0 [17.4;28.7]
|
- MI models were adjusted for gestational age, multiple pregnancy, foreign-born mother or foreign ethnicity, mother's age, parity, breastfeeding at discharge, previous cesarean section, PPROM, antepartum hemorrhage, sex, Apgar at 5 min less than 7, any respiratory support, surfactant, bronchopulmonary dysplasia, any severe morbidity, congenital anomaly, surgery in neonatal unit, hospitalized in a level III unit, SES status, region and follow-up
- IPW model were adjusted for multiple pregnancy, foreign-born mother or foreign ethnicity, mother's age, parity, breastfeeding at discharge, previous cesarean section, PPROM, respiratory support MV and CPAP, surfactant, hospitalized in a level III unit, SES status and region
- apercent increase in estimated prevalence corrected for selection bias compared to the crude estimate
